group 2 comprised 39 patients ( 56.4 % bronchogenic carcinoma , 10.1 % hypernephroma , 20.5 % primary malignancy not identifiable ) in whom the neurological symptoms due to metastasis had been first manifestation of malignancy .
C0007134
hypernephroma
C0006826
malignancy